Payer research is essential for setting the right price for a new pharmaceutical. However, it's important to recognise that there is no single "payer." In this short video, Gary Johnson, expert faculty member teaching CELforPharma’s 2-day Essentials of Value Pricing for Successful Market Access course, explains the different types of payers you need to consider before starting your pricing research.
Gary Johnson is a thought leader in this respect since he has been involved in pricing for around half of the new molecular entity launches over the past 5 years and is the author of Value Pricing for Market Access: Evidence-Based Pricing for Pharmaceuticals.
🎓 If you want to learn about:
- An overview of payer types and of national pricing & market access systems around the world.
- The concepts and language of pharma pricing and market access that confuse many executives.
- The difference between setting prices and defending prices with health economics.
- Talking to payers using surveys, interviews, and AI to get the most accurate assessment of the achievable price.
- Using AI and econometrics to analyse payer behaviour and predict future pricing behaviour.
- How to anticipate the impact of the international pricing system on your prices around the globe.
👉 Attend Gary Johnson’s and Sam Johnson’s highly praised 2-day course:
Essentials of Value Pricing for Successful Market Access
With Gary Johnson & Sam Johnson
